AbbVie Inc. — Director's Dealing 2013

Feb 6, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2013-02-04

Reporting Person: SALEKI-GERHARDT AZITA (SVP, Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-04	Common stock, $0.01 par value	M	3418	$31.9538	Acquired	27810	Direct
2013-02-04	Common stock, $0.01 par value	M	3805	$29.4031	Acquired	31615	Direct
2013-02-04	Common stock, $0.01 par value	F	6427	$37.18	Disposed	25188	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-04	Option (right to buy)	$31.9538	M	3418	Disposed	2013-02-13	Common stock (3418)	Direct
2013-02-04	Option (right to buy)	$29.4031	M	3805	Disposed	2014-02-19	Common stock (3805)	Direct
2013-02-04	Option (right to buy)	$37.18	A	3309	Acquired	2014-02-19	Common stock (3309)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, $0.01 par value	1644	Indirect
Common stock, $0.01 par value	110	Indirect

Footnotes

F1: Balance in the AbbVie Savings Program.

F2: The reporting person disclaims beneficial ownership of all securities held by her spouse.

F3: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.